Clinical Trials Browser

Phase 2 × Terminated × amrubicin × Clear all

NCT01904253 2024-09-05

A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Phase 2 Terminated

Small Cell Lung Carcinoma

NCT01331824 2018-04-23

Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma

Phase 2 Terminated

22 enrolled 12 charts

Urinary Bladder Neoplasms, Neoplasm Metastasis